Shri Sarvajanik Pharmacy College, Mehsana: Admission 2025, Courses, Fees, Cutoff, Placements, Ranking

Shri Sarvajanik Pharmacy College, Mehsana, was established in the year 1998. One of the premier institutions involved in imparting quality education in the field of pharmacy is this affiliated college, located at the heart of Mehsana, Gujarat, enlightening the future of pharmacy since 1998. The institution occupies an area of 2 acres, offering a diversity of programs in pharmacy to 303 students. There are 14 experienced faculty members, thus justifying a very conducive student-faculty ratio, assuring a personalized learning and mentorship environment.

The institution has a formidable array of infrastructure that helps in enriching the learning processes for students within its premises. There is a well-stocked library acting as a knowledge center, followed by state-of-the-art laboratories providing hands-on training, which forms an important feature of pharmacy education. The campus also contains an auditorium for events and seminars, enriching the academic environment of the institution. It also houses a first-aid facility and a gym for the proper upkeep of health and wellness for the students. The IT infrastructure of the college enables the students to keep updated with the changing times in the field of technology. For added convenience of the students, the campus has a cafeteria and a guest room for visiting relatives. The sports facilities help in building a healthy and balanced lifestyle; similarly, the separate hostel facilities for boys and girls provide a comfortable living experience for outstation students studying here.

Shri Sarvajanik Pharmacy College offers a total of four courses that include undergraduate and postgraduate programmes.

The admission process at Shri Sarvajanik Pharmacy College is devised to elect the most promising candidate for its pharmacy programs.The results of national and state-level entrance examinations, like JEE Main, NEET, or GUJCET, are accepted by the Institute for admission to its B Pharma program.